• Osako, T., Kurisaki-Arakawa, A., Dobashi, A., Togashi, Y., Baba, S., Shiozawa, S., Ishigame, H., Ishige, H., Ohno, S., Ishikawa, Y. and Takeuchi, K.
  Distinct clinicopathologic features and possible pathogenesis of localized ALK-positive histiocytosis of the breast.
  Am. J. Surg. Pathol., in press (2021)
• Isoyama, S., Mori, S., Sugiyama, D., Kojima, Y., Tada, Y., Shitara, K., Hinohara, K., Dan, S. and Nishikawa, H.

  Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.

  J. Immunother. Cancer, 9,  (2021)

   

• Miyata, K., Imai, Y., Hori, S., Nishio, M., Loo, T. M., Okada, R., Yang, L., Nakadai, T., Maruyama, R., Fujii, r., Ueda, K., Jiang, L., Zheng, H., Toyokuni, S., Sakata, T., Shirahige, K., Kojima, R., Nakayama, M., Oshima, M., Nagayama, S., Hara, E. and Takahashi, A.
  Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer.
  Proc. Natl. Acad. Sci. U. S. A., 118, e2025647118 (2021)
  
  
• Iwao, Y., Okamoto, Y., Shirahama, H., Tsukahara, S. and Tomida, A.
  eIF4B enhances ATF4 expression and contributes to cellular adaptation to asparagine limitation in BRAF-mutated A375 melanoma.
  Biochem. Biophys. Res. Commun., 573, 93-99 (2021)
• Tanaka, M. and Nakamura, T.
  Modeling fusion gene-associated sarcoma: Advantages for understanding sarcoma biology and pathology.
  Pathol. Int.,  in press (2021)

more